High Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations

Progressing a potential candidate from identification to formulation and through to manufacture is an expensive process. As costs increase exponentially the further a drug moves down the pipeline, failure at an advanced development phase can result in a substantial loss of investment. Assessing a drug candidate’s suitability during pre-formulation is, therefore, essential to minimize the risk of costly downstream failure.